NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
22nd Century Group Inc. Common Stock (NASDAQ: XXII)
XXII Technical Analysis
5
As on 9th Jun 2023 XXII STOCK Price closed @ 0.58 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.85 & Strong Sell for SHORT-TERM with Stoploss of 2.41 we also expect STOCK to react on Following IMPORTANT LEVELS. |
XXIISTOCK Price
Open | 0.63 | Change | Price | % |
High | 0.63 | 1 Day | -0.03 | -4.92 |
Low | 0.57 | 1 Week | -0.04 | -6.45 |
Close | 0.58 | 1 Month | -0.15 | -20.55 |
Volume | 2016000 | 1 Year | -1.63 | -73.76 |
52 Week High 3.31 | 52 Week Low 0.59 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
XXII Daily Charts |
XXII Intraday Charts |
Whats New @ Bazaartrend |
XXII Free Analysis |
|
XXII Important Levels Intraday
RESISTANCE | 0.70 |
RESISTANCE | 0.66 |
RESISTANCE | 0.64 |
RESISTANCE | 0.61 |
SUPPORT | 0.55 |
SUPPORT | 0.52 |
SUPPORT | 0.50 |
SUPPORT | 0.46 |
XXII Forecast May 2024
4th UP Forecast | 2.39 |
3rd UP Forecast | 1.81 |
2nd UP Forecast | 1.45 |
1st UP Forecast | 1.09 |
1st DOWN Forecast | 0.07 |
2nd DOWN Forecast | -0.29 |
3rd DOWN Forecast | -0.65 |
4th DOWN Forecast | -1.23 |
XXII Weekly Forecast
4th UP Forecast | 1.74 |
3rd UP Forecast | 1.37 |
2nd UP Forecast | 1.14 |
1st UP Forecast | 0.91 |
1st DOWN Forecast | 0.25 |
2nd DOWN Forecast | 0.02 |
3rd DOWN Forecast | -0.21 |
4th DOWN Forecast | -0.58 |
XXII Forecast2024
4th UP Forecast | 6.26 |
3rd UP Forecast | 4.44 |
2nd UP Forecast | 3.31 |
1st UP Forecast | 2.19 |
1st DOWN Forecast | -1.03 |
2nd DOWN Forecast | -2.15 |
3rd DOWN Forecast | -3.28 |
4th DOWN Forecast | -5.1 |
22nd Century Group Inc. Common Stock ( NASDAQ USA Symbol : XXII )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
XXII Other Details
Segment | EQ | |
Market Capital | 457285376.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
XXII Address
XXII Latest News
XXII Business Profile
22nd Century Group, Inc., a biotechnology company, develops plant-based solutions for the life science, consumer product, and pharmaceutical markets. It develops very low nicotine content tobacco and cigarette products under the Moonlight and Moonlight Menthol names; and SPECTRUM research cigarettes for use in independent clinical studies. 22nd Century Group, Inc. has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York. Address: 500 Seneca Street, Buffalo, NY, United States, 14204
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service